Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton's Jelly, an Extraembryonic Source.

Laroye, Caroline; Gauthier, Mélanie; Antonot, Hélène; Decot, Véronique; Reppel, Loïc; Bensoussan, Danièle

Laroye, Caroline; Gauthier, Mélanie; Antonot, Hélène; Decot, Véronique; Reppel, Loïc; Bensoussan, Danièle.

Afiliação

Laroye C; CHRU de Nancy, Unité de Thérapie Cellulaire et banque de tissus, 54500 Vandoeuvre-lès-Nancy, France.
Gauthier M; CNRS, UMR 7365, 54500 Vandoeuvre-lès-Nancy, France.
Antonot H; Faculté de Pharmacie, Université de Lorraine, 54000 Nancy, France.
Decot V; CHRU de Nancy, Unité de Thérapie Cellulaire et banque de tissus, 54500 Vandoeuvre-lès-Nancy, France.
Reppel L; CNRS, UMR 7365, 54500 Vandoeuvre-lès-Nancy, France.
Bensoussan D; Faculté de Pharmacie, Université de Lorraine, 54000 Nancy, France.

J Clin Med ; 8(12)2019 Dec 14.

Article em En | MEDLINE | ID: mdl-31847319

Palavras-chave

Wharton's jelly; bone marrow; good manufacturing practice; mesenchymal stem/stromal cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google